Get the Stockscreener App
0.8709
3.50%
-0.0316
After Hours:
.88
0.0091
+1.04%
Prelude Therapeutics Inc Stock (PRLD) Forecast
The Prelude Therapeutics Inc (PRLD) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $10.27, representing a +1,079% increase from the current price of $0.8709. The highest analyst price target is $14.03, and the lowest is $6.5082.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PRLD Price Target
Average 12.77
(+1,366% Upside)
Is Prelude Therapeutics Inc (PRLD) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 37.59 | Neutral |
| STOCH(9,6) | 12.48 | Buy |
| STOCHRSI(14) | 7.1994 | Buy |
| MACD(12,26) | -0.0634 | Sell |
| ADX(14) | 14.21 | Neutral |
| William %R | -99.10 | Buy |
| CCI(14) | -87.92 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.9468
Sell
|
0.9517
Sell
|
| MA20 |
1.0444
Sell
|
1.008
Sell
|
| MA50 |
1.0821
Sell
|
1.1358
Sell
|
| MA100 |
1.2605
Sell
|
1.5717
Sell
|
| MA200 |
2.8246
Sell
|
2.2463
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, PRLD could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on PRLD, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 37.59 indicates that PRLD is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 12.48 indicates that PRLD is oversold. This indicates that PRLD price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 7.1994 indicates that PRLD is oversold. This suggests that PRLD price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 14.21 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -87.92 indicates that PRLD is still oversold but not to an extreme extent.
Long-term PRLD price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Prelude Therapeutics Inc financial reports and earnings history, Prelude Therapeutics Inc (PRLD) stock could reach $29.16 by 2030, $17.93 by 2040 and $115.15 by 2050. See the projected annual prices until 2050 of the Prelude Therapeutics Inc stock below:
- Prelude Therapeutics Inc (PRLD) is expected to reach an average price of $26.47 in 2035, with a high prediction of $28.26 and a low estimate of $27.51. This indicates an $2,940% rise from the last recorded price of $0.8709.
- Prelude Therapeutics Inc (PRLD) stock is projected to chart a bullish course in 2040, with an average price target of $17.42, representing an $1,900% surge from its current level. The forecast ranges from a conservative $17.42 to a sky-high $17.93.
- Our analysts predict Prelude Therapeutics Inc (PRLD) to jump 12,279% by 2045, soaring from $108.56 to an average price of $107.81, potentially reaching $106.16. While $108.56 is the low estimate, the potential upside is significant.
- Prelude Therapeutics Inc (PRLD) stock is expected to climb by 2050, reaching an average of $115.60, a $13,173% jump from its current level. However, a wide range of estimates exists, with high and low targets of $115.15 and $115.65, respectively, highlighting the market's uncertainty.
Prelude Therapeutics Inc Stock (PRLD) Year by Year Forecast
Prelude Therapeutics Inc Stock (PRLD) Price Forecast for 2025
Prelude Therapeutics Inc Stock (PRLD) is expected to reach an average price of $12.03 in 2025, with a high prediction of $21.90 and a low estimate of $2.1559. This indicates an +1,281% rise from the last recorded price of $0.8709.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $9.0098 | $6.5082 | $14.03 | +934.54% |
| April, 2025 | $13.78 | $8.0796 | $21.90 | +1,483% |
| May, 2025 | $5.1272 | $5.2272 | $15.65 | +488.72% |
| June, 2025 | $3.318 | $3.628 | $4.0124 | +280.99% |
| July, 2025 | $6.0241 | $4.4833 | $5.5739 | +591.72% |
| August, 2025 | $7.015 | $6.4794 | $5.73 | +705.49% |
| September, 2025 | $9.3259 | $9.6317 | $9.3807 | +970.84% |
| October, 2025 | $8.042 | $8.9918 | $8.8311 | +823.41% |
| November, 2025 | $9.5429 | $9.7072 | $9.3125 | +995.75% |
| December, 2025 | $11.42 | $10.71 | $10.76 | +1,211% |
Prelude Therapeutics Inc Stock (PRLD) Price Forecast for 2026
The predicted value for Prelude Therapeutics Inc (PRLD) in 2026 is set at an average of $8.8948. Estimates vary from a peak of $12.20 to a trough of $5.5896, indicating an +921.33% surge from the present price of $0.8709.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $12.32 | $12.31 | $12.20 | +1,315% |
| February, 2026 | $11.73 | $12.32 | $12.11 | +1,247% |
| March, 2026 | $10.80 | $11.21 | $11.31 | +1,140% |
| April, 2026 | $10.45 | $10.41 | $10.45 | +1,100% |
| May, 2026 | $7.2087 | $7.1934 | $9.123 | +727.72% |
| June, 2026 | $7.5895 | $7.6845 | $6.8773 | +771.46% |
| July, 2026 | $7.7456 | $7.9448 | $7.2348 | +789.38% |
| August, 2026 | $4.9965 | $6.6576 | $6.6761 | +473.72% |
| September, 2026 | $7.9426 | $6.4439 | $6.2822 | +812.00% |
| October, 2026 | $7.8535 | $7.9683 | $7.5079 | +801.77% |
| November, 2026 | $5.6244 | $5.7892 | $6.2587 | +545.81% |
| December, 2026 | $5.7705 | $5.5896 | $5.705 | +562.59% |
Prelude Therapeutics Inc Stock (PRLD) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Prelude Therapeutics Inc (PRLD) is $3.4513, with a high forecast of $5.0757 and a low forecast of $1.8268. This indicates an +296.29% increase from the last price of $0.8709.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.5314 | $5.5714 | $5.0757 | +420.31% |
| February, 2027 | $4.3723 | $4.6023 | $4.1845 | +402.04% |
| March, 2027 | $4.4084 | $4.1679 | $4.0384 | +406.19% |
| April, 2027 | $3.9193 | $4.1788 | $3.9288 | +350.02% |
| May, 2027 | $4.6601 | $4.7551 | $4.2697 | +435.10% |
| June, 2027 | $4.7963 | $4.5654 | $4.6463 | +450.72% |
| July, 2027 | $4.3271 | $4.3971 | $4.4215 | +396.86% |
| August, 2027 | $4.438 | $4.4824 | $4.358 | +409.59% |
| September, 2027 | $5.2641 | $4.7632 | $4.9541 | +504.45% |
| October, 2027 | $3.165 | $3.305 | $4.3613 | +263.42% |
| November, 2027 | $1.6859 | $2.9259 | $2.9954 | +93.58% |
| December, 2027 | $2.212 | $1.8268 | $1.542 | +153.99% |
Prelude Therapeutics Inc Stock (PRLD) Price Forecast for 2028
In 2028, Prelude Therapeutics Inc (PRLD) is projected to reach an average price of $22.39, with a high projection of $44.74 and a low estimate of $0.0492. This indicates an +2,471% rise from the last price of $0.8709.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.9429 | $1.9824 | $1.7079 | +123.09% |
| February, 2028 | $0.0462 | $0.5038 | $0.2133 | -94.69% |
| March, 2028 | $0.7301 | $0.3406 | $1.0101 | -16.16% |
| April, 2028 | $0.2592 | $0.0492 | $2.0897 | -70.23% |
| May, 2028 | $6.0213 | $0.254 | $16.32 | +591.39% |
| June, 2028 | $1.0331 | $3.8538 | $4.0482 | +18.62% |
| July, 2028 | $19.78 | $4.3275 | $36.82 | +2,171% |
| August, 2028 | $33.34 | $1.9847 | $34.13 | +3,729% |
| September, 2028 | $6.8412 | $0.4824 | $44.74 | +685.53% |
| October, 2028 | $5.7006 | $2.5603 | $13.26 | +554.57% |
| November, 2028 | $6.4428 | $8.6311 | $10.57 | +639.79% |
| December, 2028 | $12.20 | $9.1718 | $7.8646 | +1,301% |
Prelude Therapeutics Inc Stock (PRLD) Price Forecast for 2029
The 2029 price forecast for Prelude Therapeutics Inc Stock (PRLD) is $18.21 on average, with a high prediction of $28.50 and a low estimate of $7.9117. This represents an +1,991% increase from the previous price of $0.8709.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $17.19 | $14.83 | $13.15 | +1,873% |
| February, 2029 | $10.84 | $17.12 | $16.39 | +1,145% |
| March, 2029 | $12.98 | $13.54 | $11.06 | +1,390% |
| April, 2029 | $10.23 | $7.9117 | $5.4508 | +1,075% |
| May, 2029 | $26.08 | $10.55 | $9.4839 | +2,895% |
| June, 2029 | $23.82 | $24.13 | $24.85 | +2,635% |
| July, 2029 | $25.79 | $24.87 | $25.61 | +2,861% |
| August, 2029 | $26.48 | $26.29 | $25.22 | +2,941% |
| September, 2029 | $28.33 | $28.98 | $28.50 | +3,153% |
| October, 2029 | $26.47 | $27.42 | $27.72 | +2,940% |
| November, 2029 | $27.52 | $28.02 | $27.51 | +3,059% |
| December, 2029 | $28.45 | $28.37 | $28.01 | +3,166% |
Prelude Therapeutics Inc Stock (PRLD) Price Forecast for 2030
Prelude Therapeutics Inc Stock (PRLD) is expected to reach an average price of $23.32 in 2030, with a high forecast of $29.16 and a low forecast of $17.48. This signifies an +2,578% surge from the last price of $0.8709.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $29.26 | $28.92 | $29.16 | +3,260% |
| February, 2030 | $28.21 | $28.80 | $28.82 | +3,139% |
| March, 2030 | $26.82 | $27.23 | $27.56 | +2,980% |
| April, 2030 | $25.22 | $25.98 | $26.35 | +2,795% |
| May, 2030 | $22.20 | $22.24 | $24.88 | +2,449% |
| June, 2030 | $22.12 | $22.21 | $21.65 | +2,440% |
| July, 2030 | $21.70 | $22.02 | $21.65 | +2,392% |
| August, 2030 | $18.49 | $20.15 | $20.40 | +2,023% |
| September, 2030 | $18.98 | $19.72 | $19.43 | +2,080% |
| October, 2030 | $20.32 | $20.51 | $20.32 | +2,233% |
| November, 2030 | $17.63 | $17.91 | $18.61 | +1,924% |
| December, 2030 | $17.56 | $17.48 | $17.37 | +1,916% |
0.27%
3.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):